The standard contains eight quality statements that describe the health care that people of all ages with cognitive disability or impairment should receive to ensure the safe and appropriate use of psychotropic medicines.
Indicators have been developed to support monitoring of the care recommended in the standard. Clinicians and healthcare services can use the indicators to support local quality improvement activities.
Information for healthcare services to guide practice and monitor improvement using the clinical care standard, and resources to support implementation.
Information about the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard and supporting resources for clinicians.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard describes the care you should expect to receive to support the safe and appropriate use of psychotropic medicines.